Sarepta Therapeutics, Inc.
- SRPT
- NASDAQ
- Biotechnology
- Gene Therapy
- RNA Therapeutics
- Rare Disease Drugs
$17.10
Today −3.88%Quote Oct 16, 2026, 08:00 PM UTC
−17.27%over the last month
Max drawdown −20.7%From 1-month high −17.8%3 months +1.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.81B
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$21.60
+26.3% from here
Floor
$16.89
1.2% below price
Where the price sits
55 analysts
Analyst range, low to high
$17.00$27.00
- Price $17.10
- Resistance $17.78
- Consensus $21.60
The price is just above its floor. Analysts' average target sits about 26% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SRPTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q3 2021 revenue $166.9M
- E X O N D Y S Fifty One$115.6M69.3%
- A M O N D Y S Fourty Five$26.7M16.0%
- V Y O N D Y S Fifty Three$24.7M14.8%
Industry
Biotechnology
Employees
835
Founded
1980